ÂÜÀòÂÒÂ×

Chloe Brown's work experience includes various roles in the medical technology industry. Chloe is currently the Chief Executive Officer at Ceroflo since October 2022. Prior to this, they worked as the Director of Strategic Marketing at Synchron from March 2020. In 2019, they served as the VP of Strategy and Business Development at Tegus Medical GmbH. Before that, they worked as a Strategic Marketing and Business Development Consultant at Port Ceres Consulting, where they assisted med-tech start-ups in developing strategic marketing and commercialization plans. Chloe had clients in various technology areas such as Interventional Neurovascular, Brain Computer Interface, Peripheral Vascular, Intravascular Imaging, Heart Failure, and Digital Therapeutics. From 2014 to 2018, Chloe was the Director of Market Development at Neuravi Ltd, an Irish start-up acquired by Johnson & Johnson. Chloe also worked as the European Marketing Manager for Acute Ischemic Stroke at Covidien (Medtronic Minimally Invasive Therapies Group) from 2011 to 2014. Starting their career at ev3 in 2009 as a Territory Sales Manager, Chloe then joined Device Technologies as the Marketing and Business Development professional for Neurovascular, Robotics, and Structural Heart from 2004 to 2008.

Chloe Brown completed their Higher School Certificate in Human Biology at Pymble Ladies College from 1983 to 1995. Chloe then pursued a Bachelor of Science in Anatomy and Physiology at the University of Sydney, graduating in 1999. Chloe furthered their education by completing a Bachelor of Nursing at the University of Technology Sydney from 2000 to 2003.